Back to Browse Journals » Virus Adaptation and Treatment » Volume 3

A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome

Authors A Martin Lerner, Safedin Beqaj

Published 21 February 2011 Volume 2011:3 Pages 19—24

DOI http://dx.doi.org/10.2147/VAAT.S15105

Review by Single-blind

Peer reviewer comments 2

A Martin Lerner1, Safedin Beqaj2
1Department of Medicine, William Beaumont Hospital, Royal Oak, MI, USA; 2DCL Medical Laboratories, Indianapolis, IN, USA

Abstract: There is no accepted science to relate herpesviruses (Epstein–Barr virus [EBV], human cytomegalovirus [HCMV], and human herpesvirus 6 [HHV6]) as causes of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). ME/CFS patients have elevated serum immunoglobulin (Ig)G serum antibody titers to EBV, HCMV, and HHV6, but there is no herpesvirus DNA-emia, herpesvirus antigenemia, or uniformly elevated IgM serum antibody titers to the complete virions. We propose that herpesvirus EBV, HCMV, and HHV6 immediate-early gene expression in ME/CFS patients leads to host cell dysregulation and host cell apoptosis without lytic herpesvirus replication. Specific antiviral nucleosides, which alleviate ME/CFS, namely valacyclovir for EBV ME/CFS and valganciclovir for HCMV/HHV6 ME/CFS, inhibit herpesvirus DNA polymerases and/or thymidine kinase functions, thus inhibiting lytic virus replication. New host cell recruitment thus ceases. In the absence of new herpesvirus, nonpermissive herpesvirus replication stops, and ME/CFS recovery ensues.

Keywords: ME/CFS, Epstein–Barr virus (EBV), human cytomegalovirus (HCMV), HHV6, abortive replication

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance

Wang G, Liu Y, Qiu P, Zhou SF, Xu L, Wen P, Wen J, Xiao X

Drug Design, Development and Therapy 2015, 9:2839-2846

Published Date: 2 June 2015

Acyclovir and hydrocortisone cream for the early treatment of recurrent cold sores

Carrie A Sailer, Spotswood L Spruance, Christopher M Hull

Virus Adaptation and Treatment 2011, 3:1-6

Published Date: 11 January 2011

Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome

A Martin Lerner, Safedin Beqaj, James T Fitzgerald, et al

Virus Adaptation and Treatment 2010, 2:47-57

Published Date: 24 May 2010

Poxviruses: smallpox vaccine, its complications and chemotherapy

Mimi Remichkova

Virus Adaptation and Treatment 2010, 2:41-46

Published Date: 20 April 2010

Conformations of the monomeric hepatitis C virus RNA-dependent RNA polymerase

Sreedhar Chinnaswamy, Ayaluru Murali, Hui Cai, et al

Virus Adaptation and Treatment 2010, 2:21-39

Published Date: 11 March 2010